McCandless D W, Schenker S, Cook M
J Clin Invest. 1968 Oct;47(10):2268-80. doi: 10.1172/JCI105912.
Thiamine-deficient encephalopathy is characterized by morphologic lesions in the brainstem and less extensively in the cerebellum, but the early neurologic signs reverse rapidly and fully with thiamine, indicating a metabolic disorder. The suggested causal mechanisms of the encephalopathy involve two thiamine-dependent enzymes: (a) impairment of pyruvate decarboxylase activity with decreased cerebral energy (ATP) synthesis, and (b) reduction of transketolase activity with possible impairment of the hexose monophosphate shunt and subsequent decrease in NADPH formation. The latter may be important in maintaining glutathione in a reduced form (GSH), which apparently functions by keeping enzymes in a reduced (active) conformation. To examine some of these postulated mechanisms, in this study we measured pyruvate decarboxylase and transketolase activity, lactate, ATP and GSH levels in the cerebral cortex, cerebellum, and brainstem, and thiamine concentration in whole brain of rats with diet-induced low thiamine encephalopathy. Pair-fed and normally fed asymptomatic control animals were similarly investigated. To assess the functional importance of some of our results, we repeated the studies in rats, immediately (16-36 hr) after reversal of the neurological signs with thiamine administration. THE DATA OBTAINED LED TO THE FOLLOWING CONCLUSIONS: (a) Brain contains a substantial reserve of thiamine in that thiamine level has to fall to below 20% of normal before the onset of overt encephalopathy and an increase in brain thiamine to only 26% of normal results in rapid reversal of neurologic signs. (b) Both cerebral transketolase and pyruvate decarboxylase activities are impaired in low thiamine encephalopathy and the abnormality in the pyruvate decarboxylase is reflected in a rise in brain lactate. These biochemical abnormalities occur primarily in the brainstem and cerebellum, the sites of the morphologic changes. (c) Although the fall in cerebral transketolase is about twofold greater than that of pyruvate decarboxylase activity during encephalopathy, both enzymes rise on reversal of neurologic signs and the degree of the transketolase rise is slight. Accordingly, this study cannot ascertain the relative functional importance of these two pathways in the induction of the encephalopathy. The data suggest, however, that the depression of transketolase is not functionally important per se, but may only be an index of some other critical aspect of the hexose monophosphate shunt. (d) The normal cerebral ATP concentration and small GSH fall during encephalopathy, with little GSH rise on reversal of neurologic signs, suggest that a depletion of neither substance is instrumental in inducing thiamine-deficient encephalopathy.
硫胺素缺乏性脑病的特征是脑干出现形态学病变,小脑病变程度较轻,但早期神经体征经硫胺素治疗后可迅速且完全逆转,提示这是一种代谢紊乱。该脑病可能的致病机制涉及两种依赖硫胺素的酶:(a) 丙酮酸脱羧酶活性受损,导致脑能量(ATP)合成减少;(b) 转酮醇酶活性降低,可能影响磷酸己糖旁路,进而使NADPH生成减少。后者对于维持谷胱甘肽的还原形式(GSH)可能很重要,GSH显然通过保持酶处于还原(活性)构象来发挥作用。为了研究其中一些假定的机制,在本研究中,我们测量了饮食诱导的低硫胺素脑病大鼠大脑皮层、小脑和脑干中的丙酮酸脱羧酶和转酮醇酶活性、乳酸、ATP和GSH水平,以及全脑中的硫胺素浓度。对配对喂养和正常喂养的无症状对照动物进行了类似的研究。为了评估我们一些结果的功能重要性,我们在给硫胺素使神经体征逆转后立即(16 - 36小时)对大鼠重复进行了研究。获得的数据得出以下结论:(a) 大脑中含有大量硫胺素储备,因为在明显的脑病发作之前,硫胺素水平必须降至正常水平的20%以下,而脑硫胺素仅增加至正常水平的26%就能使神经体征迅速逆转。(b) 在低硫胺素脑病中,脑转酮醇酶和丙酮酸脱羧酶的活性均受损,丙酮酸脱羧酶的异常表现为脑乳酸水平升高。这些生化异常主要发生在脑干和小脑,即形态学改变的部位。(c) 虽然在脑病期间脑转酮醇酶的下降幅度比丙酮酸脱羧酶活性的下降幅度大约两倍,但在神经体征逆转时,两种酶均升高,且转酮醇酶升高的程度较小。因此,本研究无法确定这两条途径在脑病诱导中的相对功能重要性。然而,数据表明,转酮醇酶的降低本身在功能上并不重要,可能只是磷酸己糖旁路其他一些关键方面的一个指标。(d) 脑病期间脑ATP浓度正常且GSH略有下降,神经体征逆转时GSH升高幅度不大,这表明这两种物质的耗竭均与硫胺素缺乏性脑病的诱导无关。